BONE GRAFTING & Nanotechnologies
Nano surface technology
Engineered for fusion.
Medtronic uses nanoscale surface engineering to enhance bone integration, combining a PEEK core with a titanium scaffold and electrochemically treated nanotube arrays.
The Anatomic™ PEEK interbody features a three-dimensional titanium scaffold with interconnected pores in order to improve implant stability, enhance radiographic visibility, and promote bone growth.
nanoLOCK™ is a proprietary surface treatment developed to enhance the osseointegration and mechanical stability of spinal implants. It has a dual-level surface architecture that combines micron-scale roughness with nanotopography.1 A micron-scale texture promotes mechanical interlock with bone.2
The nanotopography, created through a proprietary etching process, encourages cellular adhesion, proliferation, and differentiation, particularly of osteoblasts.1
The surface is applied to titanium alloy substrates and has been validated through in vitro and in vivo studies showing enhanced osteogenic activity and bone-to-implant contact.§,3
This dual-scale design mimics the natural bone environment, aiming to:
Representative of scanning electron microscopy (SEM) images of surface features at each scale.
In nature, osteoblasts form bone after osteoclastic pits have been created. nanoLOCK™ surface technology uses biomimicry to create osteoclastic-like pits that mirror the topography and nanotexture of natural pits, creating a surface based on the bone remodeling process.5
Osteoclastic pit in nature
Osteoclastic pit-like, nano-scaled texture of nanoLOCK™.6
Image courtesy of Timothy R. Arnett, PhD, University College London (UCL) and Matteson et al.8
nanoPEEK is a proprietary surface treatment engineered to enhance osseointegration and mechanical stability in spinal implants, available on both the Adaptix™ nanoPEEK interbody fusion system and Anatomic™ PEEK interbody fusion system.
† Cellular study data in Anatomic nanoPEEK IFU.
‡ Cellular study data on file, 2024.
§ In vitro performance may not be representative of clinical outcomes.